Medical Equipment

Global Molecular Diagnostics For Sexually Transmitted Diseases Market Overview: Trends Shaping Growth to 2029

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Molecular Diagnostics For Sexually Transmitted Diseases Industry In 2025?

The market size for molecular diagnostics of sexually transmitted diseases has experienced swift expansion recently. This market is projected to expand from $3.31 billion in 2024 to $3.67 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.9%. Historically, this growth stemmed from factors such as the increasing prevalence of sexually transmitted infections, the expanded application of nucleic acid amplification tests, enhanced awareness driven by government screening initiatives, backing from international health organizations, and prompt integration within diagnostic laboratories.

The molecular diagnostics for sexually transmitted diseases market size is projected to experience substantial expansion over the next few years, with an anticipated growth to $5.48 billion by 2029, at a compound annual growth rate (CAGR) of 10.5%. This growth in the forecast period is primarily driven by an increased focus on early disease detection, a rising demand for personalized diagnostics, the expansion of sexually transmitted infection surveillance programs, a proliferation of public-private partnerships, and a growing preference for non-invasive testing methods. Prominent trends throughout this period are expected to encompass technological advancements in molecular assay platforms, innovations in point-of-care diagnostic devices, the development of multiplex polymerase chain reaction (PCR)-based testing panels, continuous research and development in portable and automated systems, and the integration of artificial intelligence in result interpretation.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27351&type=smp

What Are The Drivers Pushing New Developments In The Molecular Diagnostics For Sexually Transmitted Diseases Market?

The market for molecular diagnostics for sexually transmitted diseases is anticipated to expand due to the increasing incidence of sexually transmitted infections. Sexually transmitted infections (STIs) are defined as ailments resulting from bacteria, viruses, or parasites passed during sexual activity, impacting the reproductive and urinary systems. The growing occurrence of sexually transmitted infections is predominantly linked to inconsistent adoption of protective measures. This inadequate use of protection leads to simpler transmission of these infections among sexually active people. Molecular diagnostics for sexually transmitted infections (STIs) are crucial for managing these conditions, as they allow for prompt and precise identification of pathogens, even in those without symptoms, thereby enabling early treatment, curbing disease spread, and enhancing patient well-being. An illustrative example from January 2024, provided by the National Association of County and City Health Officials (NACCHO), a US-based nonprofit organization, indicated that 3,755 congenital syphilis cases were reported, showing a 31% rise between 2021 and 2022. Consequently, the increasing prevalence of sexually transmitted infections is fueling the expansion of the molecular diagnostics for sexually transmitted diseases market.

What Are The Major Segment Types Covered In The Molecular Diagnostics For Sexually Transmitted Diseases Market?

The molecular diagnostics for sexually transmitted diseases market covered in this report is segmented

1) By Product: Instruments And Services, Consumables, Software

2) By Technology: Laboratory Testing, Point-Of-Care Testing

3) By Application: Chlamydia Trachomatis (CT) Or Neisseria Gonorrhoeae (NG) Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus (HSV) Testing, Human Papillomavirus (HPV) Testing, Human Immunodeficiency Virus (HIV) Testing, Trichomonas, Ureaplasma And Mycoplasma, Other Applications

Subsegment:

1) By Instruments And Services: Molecular Diagnostic Analyzers, Automated Polymerase Chain Reaction Systems, Nucleic Acid Extraction Instruments, Diagnostic Service Providers, Maintenance And Calibration Services, Installation And Training Services

2) By Consumables: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Nucleic Acid Probes, Control And Reference Standards, Detection Enzymes And Buffers

3) By Software: Data Interpretation And Reporting Software, Polymerase Chain Reaction Workflow Management Software, Laboratory Information Management Systems, Diagnostic Decision Support Software, Quality Control Monitoring Software

Which Key Trends Are Expected To Influence The Molecular Diagnostics For Sexually Transmitted Diseases Market In The Coming Years?

Companies operating in the molecular diagnostics for sexually transmitted diseases market are increasingly focusing on creating advanced solutions, specifically rapid point-of-care polymerase chain reaction (PCR) devices, to boost diagnostic speed, accuracy, and accessibility. These swift point-of-care PCR devices are mobile molecular diagnostic tools that merge sample preparation, amplification, and detection into one compact unit, enabling quick and highly sensitive pathogen detection away from traditional laboratory settings. For example, in March 2025, Visby Medical, a US-based diagnostic technology company, launched the Visby Medical Women’s Sexual Health Test. This product is a single-use, handheld PCR device engineered to identify chlamydia, gonorrhea, and trichomoniasis from vaginal samples within 30 minutes. It operates without requiring external instrumentation or cold-chain logistics, features an integrated amplification system, and delivers lab-quality results directly at the point of care to facilitate immediate clinical decisions. The test is authorized for prescription home use, making it the first U.S. Food and Drug Administration (FDA)-cleared molecular diagnostic test for multiple sexually transmitted infections (STIs) that can be utilized outside clinical environments. This launch indicates a move towards decentralized diagnostic options that improve access, especially in underserved or remote areas.

Which Key Market Players Are Investing In Expansion And Innovation Of Molecular Diagnostics For Sexually Transmitted Diseases Market?

Major companies operating in the molecular diagnostics for sexually transmitted diseases market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Illumina Inc., Hologic Inc., bioMérieux S.A., QuidelOrtho Corporation, QIAGEN N.V., Cepheid, Sansure Biotech Inc., OraSure Technologies Inc., Meridian Bioscience, Seegene Inc., Visby Medical Inc., Zeesan Biotech, Binx Health Inc., GCC Biotech, GeneProof, and Solone Life Sciences India (P) Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-for-sexually-transmitted-diseases-global-market-report

What Are The Regional Market Dynamics Impacting The Molecular Diagnostics For Sexually Transmitted Diseases Industry?

North America was the largest region in the molecular diagnostics for sexually transmitted diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics for sexually transmitted diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Molecular Diagnostics For Sexually Transmitted Diseases Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27351&type=smp

Browse Through More Reports Similar to the Global Molecular Diagnostics For Sexually Transmitted Diseases Market 2025, By The Business Research Company

Personal Loans Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/personal-loans-global-market-report

Trade Credit Insurance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/trade-credit-insurance-global-market-report

Household Insecticides Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/household-insecticides-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info